Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform
TAPS-ESP
1 other identifier
interventional
1,000
1 country
1
Brief Summary
The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2022
CompletedStudy Start
First participant enrolled
July 15, 2022
CompletedFirst Posted
Study publicly available on registry
July 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2024
CompletedJanuary 26, 2026
October 1, 2025
1.7 years
July 1, 2022
January 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Tobacco, Alcohol, Prescription drug, and illicit Substance Use Tool-Electronic Spanish Platform (TAPS-ESP) primary criterion validation against the modified World Mental Health Composite International Diagnostic Interview (CIDI) in Spanish
TAPS-ESP is a two-stage screening and assessment tool that first screens for 4 broad substance abuse categories (tobacco, alcohol, prescription drug misuse, and illicit substances), then branches to the assessment for specific risks related to an array of substances. TAPS-ESP scores will be validated against the modified World Mental Health Composite International Diagnostic Interview (CIDI) including alcohol, tobacco, and 9 substance categories. The CIDI items mapped to the diagnostic criteria for each substance will serve as the primary criterion standard for validation of the TAPS-ESP. For detecting CIDI-derived substance use disorder (SUD) diagnosis, we will examine TAPS-ESP cut-points for the 4-item screener and the assessment in detecting problem severity defined by CIDI for detecting different tiers of substance use: Problem use (1+ criteria), SUD (2+ criteria), and moderate-to-severe SUD (4-11 criteria). Detection of SUD will be the primary outcome for each substance category.
1 year
Secondary Outcomes (5)
Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) for concurrent and convergent validity of the TAPS Tool
1 year
Drug Abuse Screening Test (DAST-10) for concurrent and convergent validity of the TAPS Tool
1 year
CAGE (Cut Down, Annoyed, Guilty, Eye-Opener) for concurrent and convergent validity of the TAPS
1 year
Alcohol Use Disorders Identification Test (AUDIT) for concurrent and convergent validity of the TAPS
1 year
Fagerstrom Test for Nicotine Dependence (FTND) for concurrent and convergent validity of the TAPS
1 year
Study Arms (2)
Self-Administration followed by Interviewer-Administered
ACTIVE COMPARATORScreening and validation of assessment tool translated into Spanish
Interviewer-Administered followed by Self-Administration
ACTIVE COMPARATORScreening and validation of assessment tool translated into Spanish
Interventions
Screening and validation of assessment tool translated into Spanish
Eligibility Criteria
You may qualify if:
- Age 18 or older
- Current patient of the clinic
- Spanish-language preferred
- Ability to read Spanish
You may not qualify if:
- Unable to provide informed consent
- Inability to comprehend or read Spanish
- Inability to self-administer the iPad tool due to physical limitations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baylor Research Institutelead
- COG Analyticscollaborator
Study Sites (1)
Baylor Scott and White Community Care
Dallas, Texas, 75246, United States
Related Publications (1)
Gryczynski J, Sanchez K, Carswell SB, Schwartz RP. The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care. Addict Sci Clin Pract. 2023 Nov 16;18(1):69. doi: 10.1186/s13722-023-00423-9.
PMID: 37974265DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine Sanchez, PhD
Baylor Scott and White Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2022
First Posted
July 27, 2022
Study Start
July 15, 2022
Primary Completion
March 14, 2024
Study Completion
March 14, 2024
Last Updated
January 26, 2026
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Two years
- Access Criteria
- Contact Principal Investigators